Immunogenic cell death-inducing chemotherapeutic nanoformulations potentiate combination chemoimmunotherapy
Chemotherapeutic nanoformulations, which can induce the immunogenic death of tumor cells, have attracted increasing attention for their abilities to enable and potentiate combination chemoimmunotherapy. Immunogenic cell death (ICD) causes the release of tumor-associated antigens, tumor-specific anti...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-04-01
|
Series: | Materials & Design |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0264127521000186 |